The FDA permanently debarred Bernardo Garmendia, the former co-owner of a Florida research center, after Garmendia’s conviction on one count of conspiracy to commit wire fraud. Garmendia requested a hearing on the debarment in February 2024. The Federal Register notice (90 Fed. Reg. 12164) denying the hearing noted “More than 60 days have passed from the date Garmendia receiv... Read More